hiPSC-CMs were generated from the control LUMC0099iCTRL04 hiPSC line, which was derived from human fibroblasts extracted through skin biopsies from of a Caucasian woman. The LUMC0099iCTRL04 line is registered in the Human Pluripotent Stem Cell Registry (Seltmann et al., 2016 (link)), which contains all details pertaining to its generation and characterization (hPSCreg, 2019 ). hiPSC clones showing stem cell morphology were characterized for pluripotency marker expression and differentiation potential to hiPSC-CMs in BPEL medium (Ng et al., 2008 (link)) containing activin-A, BMP4, and CHIR99021 (Devalla et al., 2016 (link)). After 3 days, this medium was replaced by BPEL medium containing XAV939 (Tocris Biosciences) for ventricular differentiation (Ng et al., 2008 (link); Devalla et al., 2016 (link)). To differentiate hiPSC-CMs to atrial-like hiPSC-CMs, 1 μM all-trans retinoic acid (RA) was added (Devalla et al., 2015 (link)). Twenty days after differentiation, hiPSC-CMs were dissociated with TrypLE Select (Life Technologies), and plated at a low density (≈7.5 × 104 cells) on Matrigel coated coverslips in BPEL medium (Devalla et al., 2016 (link)).
Free full text: Click here